Metabolic changes in rat serum after administration of suberoylanilide hydroxamic acid and discriminated by SVM. (December 2017)

• Record Type: Journal Article
• Authors: Yu, J; Wu, H; Lin, Z; Su, K; Zhang, J; Sun, F; Wang, X; Wen, C; Cao, H; Hu, L
• Is Part Of: Human & experimental toxicology. Volume 36:Number 12(2017)
• Page Start: 1286
• Page End: 1294
• Publication Date: 2017-12
• Subjects: Metabolomics -- suberoylanilide hydroxamic acid -- SVM -- rat; Toxicology -- Periodicals; 615.9
• DOI: 10.1177/0960327116688067
• Languages: English
• ISSNs: 0960-3271

Abstract

Suberoylanilide hydroxamic acid (SAHA) exerts marked anticancer effects via promotion of apoptosis, cell cycle arrest, and prevention of oncogene expression. In this study, serum metabolomics and artificial intelligence recognition were used to investigate SAHA toxicity. Forty rats (220 ± 20 g) were randomly divided into control and three SAHA groups (low, medium, and high); the experimental groups were treated with 12.3, 24.5, or 49.0 mg kg −1 SAHA once a day via intragastric administration. After 7 days, blood samples from the four groups were collected and analyzed by gas chromatography–mass spectrometry, and pathological changes in the liver were examined using microscopy. The results showed that increased levels of urea, oleic acid, and glutaconic acid were the most significant indicators of toxicity. Octadecanoic acid, pentadecanoic acid, glycerol, propanoic acid, and uric acid levels were lower in the high SAHA group. Microscopic observation revealed no obvious damage to the liver. Based on these data, a support vector machine (SVM) discrimination model was established that recognized the metabolic changes in the three SAHA groups and the control group with 100% accuracy. In conclusion, the main toxicity caused by SAHA was due to excessive metabolism of saturated fatty acids, which could be recognized by an SVM model.